Brief: Repare Therapeutics FY EPS USD -2.23
28/02/2024 12:05
Feb 28 (Reuters) - Repare Therapeutics FY pretax profit USD -103.179 million. * FY operating expenses USD 167.357 million * FY income from operations USD -116.224 million * FY net income USD -93.796 million
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln